Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4393 Surufatinib plus trans arterial embolisation (TAE) vs. surufatinib monotherapy in neuroendocrine tumour with liver metastasis: Updated results from the prospective, randomised, controlled trial

Introduction: The liver is the main metastasis site for NETs. Surufatinib (SUR), an oral TKI, is standard therapy for advanced NETs. TAE is the primary local intervention for unresectable hepatic NETs.

Conference:

Presenting Author: Cao D

Authors: Cao D, Li X, You X, Li R, Xiang J,

Keywords: NET, Liver metastasis, Surufatinib, TAE,

#4218 Primary hepatic neuroendocrine tumor in a series of 8 cases

Introduction: Primary neuroendocrine (NET) tumors of the liver are extremely rare, accounting for 0.3% of all NETs; unlike metastatic neuroendocrine tumors, rarely cause carcinoid syndrome. Edmonson reported the first case in 1958. Since then, fewer than 150 cases have been reported in the literature. Before making the diagnosis of primary hepatic neuroendocrine tumor it is imperative to explore the patients, several radiological investigations can help to pinpoint the primary which is most often digestive.

Conference:

Presenting Author:

Authors: Samia K, Fatima H, Benali T, Nabil B, Aisha B,

Keywords: neuroendocrine tumor, primary, hepatic, metastasis, rare, neuroendocrin carcinoma,

#3397 Molecular deciphering of primary liver neuroendocrine neoplasms confirms its distinct existence with foregut-like profile

Introduction: Isolated hepatic localizations of neuroendocrine tumors (NETs) are generally considered as metastatic NETs of unknown primary but could correspond to primary hepatic NETs (PHNETs), a poorly explored entity.

Conference:

Presenting Author:

Authors: de Mestier L, Nicolle R, Poté N, Rebours V, Hentic O,

Keywords: liver, unknown primary, DNA sequencing, RNA sequencing, immunohistochemistry,

#1061 Transcatheter Arterial Chemoembolization for Unresectable Metastatic Hepatic Lesions of Pancreatic Neuroendocrine Tumors

Introduction: The blood supply of metastatic hepatic neuroendocrine tumors is mainly supplied by hepatic arteries. For unresectable metastatic NETs, selective embolisation of the hepatic arteries may be therapeutic.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Liu L, Xu X,

Keywords: pnet, hepatic lesion, tace,

#1035 Liver Transplantation for Metastatic Hepatic Neuroendocrine Tumors of Unknown Origin

Introduction: Liver transplantation can be implemented on patients with diffuse hepatic tumors, but for hepatic NETs its role and value are still unclear.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Zhou J, Xu x,

Keywords: hepatic nets, lt,